Aksys home haemodialysis system gains FDA nod
This article was originally published in Clinica
Executive Summary
Aksys is gearing up to launch its personal haemodialysis (PHD) system in the US, which could allow kidney failure patients to perform haemodialysis more frequently and more cost-effectively in the home setting.